198 related articles for article (PubMed ID: 21263160)
1. Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.
Kimple RJ
Mol Interv; 2010 Dec; 10(6):341-53. PubMed ID: 21263160
[TBL] [Abstract][Full Text] [Related]
2. New radiosensitizing regimens, drugs, prodrugs, and candidates.
Vallerga AK; Zarling DA; Kinsella TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
[TBL] [Abstract][Full Text] [Related]
3. Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.
Pauwels B; Wouters A; Peeters M; Vermorken JB; Lardon F
Future Oncol; 2010 Sep; 6(9):1485-96. PubMed ID: 20919831
[TBL] [Abstract][Full Text] [Related]
4. New and emerging radiosensitizers and radioprotectors.
Spalding AC; Lawrence TS
Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698
[TBL] [Abstract][Full Text] [Related]
5. Principles of chemoradiation: theoretical and practical considerations.
Herscher LL; Cook JA; Pacelli R; Pass HI; Russo A; Mitchell JB
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):11-22. PubMed ID: 10550823
[TBL] [Abstract][Full Text] [Related]
6. [Biological basis for concomitant chemoradiotherapy in carcinomas].
Favaudon V; Noël G
Bull Cancer; 2005 Dec; 92(12):1027-31. PubMed ID: 16396748
[TBL] [Abstract][Full Text] [Related]
7. Biologic basis for combining drugs with radiation.
Wilson GD; Bentzen SM; Harari PM
Semin Radiat Oncol; 2006 Jan; 16(1):2-9. PubMed ID: 16378901
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
Sartor CI
Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
[TBL] [Abstract][Full Text] [Related]
9. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
11. Targeting base excision repair as a sensitization strategy in radiotherapy.
Vens C; Begg AC
Semin Radiat Oncol; 2010 Oct; 20(4):241-9. PubMed ID: 20832016
[TBL] [Abstract][Full Text] [Related]
12. Antimetabolite radiosensitizers.
Shewach DS; Lawrence TS
J Clin Oncol; 2007 Sep; 25(26):4043-50. PubMed ID: 17827452
[TBL] [Abstract][Full Text] [Related]
13. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
Deutsch E; Soria JC; Armand JP
Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs.
Chen AY; Chou R; Shih SJ; Lau D; Gandara D
Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660
[TBL] [Abstract][Full Text] [Related]
15. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
16. Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets.
Kvols LK
J Nucl Med; 2005 Jan; 46 Suppl 1():187S-90S. PubMed ID: 15653668
[TBL] [Abstract][Full Text] [Related]
17. Chemical radiosensitizers for use in radiotherapy.
Wardman P
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
[TBL] [Abstract][Full Text] [Related]
18. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ.
Iliakis G; Wu W; Wang M
Int J Hyperthermia; 2008 Feb; 24(1):17-29. PubMed ID: 18214766
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of radiation response of prostatic carcinoma by lonidamine.
Dudak SD; Lopez A; Block NL; Lokeshwar BL
Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells.
Iliakis G; Pantelias G; Kurtzman S
Radiat Res; 1991 Jan; 125(1):56-64. PubMed ID: 1986401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
